PHYSICIAN WORK ENVIRONMENT AND WELL-BEING

Workplace Factors Associated With Burnout of Family Physicians
Burnout is on the rise, with over half of US physicians reporting at least 1 symptom in 2014.
1 Physician burnout has negative impacts on both physician well-being and patient care. Addressing burnout is imperative to improving the care of patients, promoting the health of physicians, and reducing health care costs. Practice features associated with burnout include clinic demands, paperwork, and maintaining work/life balance. 2 Our purpose was to examine burnout in a national sample of board certified family physicians.
Methods | We used data from the family physicians seeking to continue their American Board of Family Medicine (ABFM) certification in 2016. All examinees completed an application questionnaire with core questions and 1 of 5 additional question sets. The strategy produces representative samples. In adjusted analyses, we found positive independent associations between job stress (OR, 16.38; 95% CI, ) and excessive time spent on EMRs at home (OR, 2.67; 95% CI, 2.12-3.38) with burnout ( Table 2) . Controlling for all variables in the Mini Z simultaneously attenuated the strength of the associations for all variables and resulted in efficient team work, excessive time spent on EMRs at home, and EMR proficiency losing statistical significance.
Discussion | In a national sample of family physicians, 25% reported symptoms of burnout, which is substantially lower than estimates using the Maslach Burnout Inventory (63%) 1 but is closer to estimates of academic general internists (38%) using the Mini Z. 2 Burnout was associated with multiple workplacerelated factors, with the strongest associations being stress and hectic/chaotic work area. Electronic medical record-related variables were not significant when controlling for other workplace factors, whereas insufficiency of time for documentation remained significant. With recent findings that physicians spend half as much time on direct clinical contact as on EMRs and desk work, 4 our findings concur with others that the tasks required for EMR use are associated with burnout, not the EMR itself. 5 This disproportionate time documenting may decrease the potentially protective benefits of patient contact.
6
Our study has several limitations. First, although the sample was national, early career physicians are undersampled because recertification occurs at least 7 years after residency. Furthermore, because the Mini Z only correlates with 1 domain of burnout, the difference in prevalence with other studies may be owing to the use of different assessments.
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Letters Conclusions | Our findings suggest that burnout among family physicians is not uncommon. Future interventions to reduce burnout and improve patient care and physician satisfaction can be targeted toward addressing workplace factors. 
Association of Appearance of Conflicts of Interest With Voting Behavior at FDA Advisory Committee Meetings-A Cross-sectional Study
To ensure objectivity on the 49 advisory committees (ACs) of the US Food and Drug Administration (FDA), the FDA reviews disclosure statements submitted by members for 2 potentially disqualifying types of financial conflict of interest (COI): "section 208 conflicts" (regulated under 18 USC §208 1 ) and, for those without section 208 conflicts, "section 502 conflicts" (regulated under 5 CFR §2635.502 2 ). While section 208 conflicts are created by current financial interests, section 502 conflicts are typically created by past financial interests or personal and business relationships that could create the appearance of a conflict. For both, the FDA may either exclude the individual from participation or allow participation when permitted by statute. The FDA publicly discloses section 208 conflicts 3 but not section 502 conflicts and has recently requested comments about whether these conflicts should be publicly disclosed. 4, 5 We examined the prevalence of section 502 conflicts and their associations with voting behavior at FDA AC meetings.
Methods | We obtained internal agency information for AC meetings with votes on drugs and devices held between 2008 and 2014 for which COI screening was required. For meetings with section 502 conflicts present, we determined the prevalence and characteristics of both section 208 and section 502 conflicts and, for meetings related to particular products, assessed whether members with section 502 conflicts were more likely to vote with the majority than were members without these conflicts. For meetings with no section 208 conflicts and where the vote was not unanimous, we assessed whether the prevalence of section 502 conflicts was associated with the percentage of votes favorable to the product and with the meeting outcome. Finally, we examined whether excluding members with section 502 conflicts would have changed the meeting outcome. Institutional review board approval was not required because the study was not considered human subjects research.
Results | Of 385 AC meetings that met entry criteria, 27.3% (n = 105) included at least 1 voting member with a section 502 conflict; there was no trend over time. Of 1482 voting members in these meetings, 12.6% (n = 187) had section 502 conflicts only; 0.8% (n = 12) had section 208 conflicts only, and 0.9% (n = 14) had both. More detail is reported in Table 1 . Individuals with only section 502 conflicts were typically organizational officers (36.9%; n = 69), had conflicts with sponsoring firms (89.3%; n = 167), and had imputed COIs (ie, COIs assigned based on members' personal relationships or employment) (61.0%; n = 114). Voting members with only section 208 conflicts were more likely than those with 502 conflicts to have conflicts with competing firms (58.3% [n = 7] vs 8.6% [n = 16]; Pearson χ 2 P < .001) but were otherwise similar. The median values of section 502 and 208 conflicts were $30 000 and under $50 000, respectively (the financial value of section 208 conflicts is reported in ranges). Of 151 votes on specific medical products by members with only section 502 conflicts, 132 (87.4%) concurred with the majority (Table 2) . We found no association between the prevalence of section 502 conflicts and voting outcomes. Excluding members with section 502 conflicts generally would have produced voting margins more favorable to the product, but in no instance would the meeting outcome have changed between favoring and opposing the product. In 1 instance, excluding 2 members with only a section 502 conflict would have led to a tie vote rather than a vote opposing the product.
Discussion | Between 2008 and 2014, about a quarter of FDA AC meetings that met entry criteria included at least 1 participant with a section 502 conflict. Members with section 502 conflicts had voting patterns similar to those without such conflicts; there was no association between section 502 conflicts and meeting outcomes.
The study limitations were as follows: (1) including only meetings where at least 1 member had a section 502 conflict; (2) small sample sizes, particularly in the voting analyses; and (3) inability to control for other factors that might
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